Revelation Biosciences Stock Target Price and Analyst Consensus
| REVB Stock | USD 3.00 0.02 0.67% |
The current analyst and expert consensus on Revelation Biosciences is Buy, with no strong buy opinions. The current projected Revelation Biosciences target price consensus is 12.75 with 1 analyst opinions. Check out Macroaxis Advice on Revelation Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.The most common way Revelation Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Revelation Biosciences executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Revelation Biosciences. We encourage you to use your own analysis of Revelation Biosciences to validate this buy or sell advice. Revelation Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Revelation Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 8.9372.
Lowest Forecast 11.6 | Highest Forecast 14.15 | Target Price 12.75 |
Revelation |
It's important to approach Revelation Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Revelation Biosciences Target Price Consensus
Revelation target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Revelation Biosciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Buy |
Most Revelation analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Revelation stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Revelation Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationRevelation Biosciences Target Price Projection
Revelation Biosciences' current and average target prices are 3.00 and 12.75, respectively. The current price of Revelation Biosciences is the price at which Revelation Biosciences is currently trading. On the other hand, Revelation Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Revelation Biosciences Market Quote on 25th of March 2025
Target Price
Analyst Consensus On Revelation Biosciences Target Price
Revelation Biosciences Analyst Ratings
Revelation Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Revelation Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Revelation Biosciences' financials, market performance, and future outlook by experienced professionals. Revelation Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Revelation Biosciences price targets
Revelation Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Revelation Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Revelation Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Revelation Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Revelation Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Revelation Biosciences is a key component of Revelation Biosciences valuation and have some predictive power on the future returns of a Revelation Biosciences.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Revelation Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cancer Fighters Invested over 90 shares | |
 | Air Invested over 400 shares | |
 | Macroaxis Index Invested over 200 shares | |
 | Compulsion Invested over 20 shares | |
 | Precious Metals Invested over 100 shares | |
 | Power Assets Invested over 300 shares | |
 | Adviser Favorites Invested few shares | |
 | Momentum Invested few shares | |
 | Driverless Cars Invested over 300 shares | |
Check out Macroaxis Advice on Revelation Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, the presentation of Revelation Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Revelation Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Revelation Biosciences' management manipulating its earnings.